Search results
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 10 hours agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell...
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Zacks via Yahoo Finance· 4 days agoShattuck (STTK) will now focus on higher-risk myelodysplastic syndromes and TP53 mutant acute...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 14 hours agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 2 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat ...
Avidity Up 33% on Rare Muscle Disease Study Results - Arcutis Biotherapeutics (NASDAQ:ARQT), Heron...
Benzinga· 5 days agoAvidity Biosciences RNA announced encouraging initial data from the phase I/II FORTITUDE study...
Elion secures $81m to advance antifungal therapy
Pharmaceutical Technology via Yahoo Finance· 1 day agoElion’s antifungal therapy SF001 targets aspergillosis, which can be caused by Aspergillus fumigatus, a pathogen of critical priority as per the WHO.
Citi maintains Buy rating on Cabaletta Bio post-EULAR data By Investing.com
Investing.com· 2 days agoOn Monday, Citi reaffirmed its positive stance on Cabaletta Bio Inc . The endorsement follows the...
Exploring Undervalued Small Caps With Insider Buying In Hong Kong June 2024
Simply Wall St. via Yahoo Finance· 2 days agoAs of June 2024, the Hong Kong market reflects a cautious sentiment, mirroring broader global...
Lantern Pharma secures Japan patent for cancer drug By Investing.com
Investing.com· 6 days agoLantern Pharma Inc. (NASDAQ:LTRN), a company leveraging artificial intelligence (AI) in cancer...
Stocks In Play: Cardiol Therapeutics Inc. By Baystreet.ca
Investing.com· 2 days agoStocks In Play: Cardiol Therapeutics Inc.